CDNF and Parkinson disease: Recombinant CDNF protein has been shown to reduce levels of the Atf6 UPR transcript in thapsigargin-treated embryonic mouse dopamine neurons in vitro and the level of GRP78 protein and ATF6 transcripts in the rat striatum in a 6-OHDA model of Parkinson’s disease in vivo [27].